Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia

M C Grégoire1, F Lefebvre, J Glorieux

  • 1Université de Montréal, Hôpital Ste-Justine and Université de Montréal, Montréal, Canada.

Pediatrics
|May 23, 1998
PubMed

Insights

Very preterm infants needing oxygen at 28 days but not 36 weeks (BPD-1) showed no increased risk of morbidities. However, those needing oxygen past 36 weeks (BPD-2) had more respiratory issues and developmental delays.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Developmental Pediatrics

Background:

  • Very preterm infants often require respiratory support.
  • Oxygen dependency at different post-natal or gestational ages may indicate varying risks for long-term morbidities.

Purpose of the Study:

  • To assess the 18-month morbidities in very preterm infants.
  • To compare outcomes for infants oxygen-dependent at 28 days but not 36 weeks (BPD-1) versus those oxygen-dependent at 36 weeks (BPD-2) and a comparison group.

Main Methods:

  • A cohort of 217 infants born between 24-28 weeks gestation were categorized into three groups based on oxygen use.
  • Outcomes assessed at 18 months included growth, respiratory problems, surgery, hospitalizations, and neurodevelopmental impairments.

Main Results:

  • Infants in the BPD-1 group (oxygen < 36 weeks) showed no significant differences in growth, hospitalizations, or neurodevelopment compared to controls.
  • Infants in the BPD-2 group (oxygen ≥ 36 weeks) experienced more hernia repairs, longer respiratory rehospitalizations, and lower developmental quotients.

Conclusions:

  • Very preterm infants not oxygen-dependent by 36 weeks (BPD-1) have similar 18-month outcomes to non-oxygen-dependent peers.
  • Prolonged oxygen dependency (BPD-2) is associated with increased respiratory morbidity, surgical needs, and developmental delays at 18 months.
Abstract

Related Concept Videos

Assessment of Respiration01:23

Assessment of Respiration

The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...